Menu
ETF
Annual · values202620242023202220212020201820172016201520142012
Operating Cash Flow-34.23 M USD15.72 M USD14.59 M USD35.72 M USD43.96 M USD25.80 M USD12.77 M USD2.85 M USD1.05 M USD-7.95 M USD3.35 M USD3.22 M USD
Depreciation & Amortization8.32 M USD6.89 M USD5.11 M USD4.48 M USD3.61 M USD3.67 M USD2.43 M USD3.13 M USD2.66 M USD2.08 M USD1.71 M USD1.31 M USD
Stock-Based Compensation30.59 M USD27.21 M USD23.52 M USD20.37 M USD14.61 M USD10.55 M USD6.76 M USD3.16 M USD8.56 M USD4.66 M USD4.49 M USD3.21 M USD
Capital Expenditures5.82 M USD23.39 M USD18.19 M USD18.11 M USD13.64 M USD10.10 M USD2.25 M USD1.05 M USD3.21 M USD4.05 M USD3.45 M USD2.27 M USD
Cash Flow from Investing46.34 M USD-59.22 M USD74.35 M USD-156.38 M USD-13.64 M USD-10.18 M USD-2.25 M USD-1.05 M USD-3.21 M USD-4.05 M USD-3.45 M USD-2.15 M USD
Cash Flow from Financing-4.55 M USD5.72 M USD7.42 M USD8.30 M USD17.79 M USD149000 USD74.64 M USD2.44 M USD2.95 M USD2.53 M USD2.44 M USD4.28 M USD
Dividends Paid
Stock Buybacks6.46 M USD
Free Cash Flow-40.05 M USD-7.67 M USD-3.59 M USD17.61 M USD30.32 M USD15.70 M USD10.52 M USD1.81 M USD-2.16 M USD-12.01 M USD-93000 USD946000 USD

Staar Surgical Company designs, develops, manufactures, and sells implantable lenses for eye surgery, operating primarily in the ophthalmic medical devices sector. The company offers two main product categories: Implantable Collamer lenses (ICL) used in refractive surgery to correct vision problems without removing the eye's natural lens, and intraocular lenses (IOL) used in cataract surgery. Staar Surgical delivers these products through specialized accessory delivery systems designed for surgical use. With over 2.5 million implants performed worldwide, the company serves ophthalmic surgeons and surgical centers globally. The ophthalmic surgical product segment generates the majority of Staar Surgical's revenue. Founded in 1982 and headquartered in Lake Forest, California, Staar Surgical operates as a medical device manufacturer focused on vision correction and cataract treatment solutions for healthcare providers and patients seeking surgical vision correction alternatives.